Related Experiment Video

Updated: May 8, 2026

Live Cell Imaging to Assess the Dynamics of Metaphase Timing and Cell Fate Following Mitotic Spindle Perturbations
07:14

Live Cell Imaging to Assess the Dynamics of Metaphase Timing and Cell Fate Following Mitotic Spindle Perturbations

Published on: September 20, 2019

Centrosomal kinase Nek2 cooperates with oncogenic pathways to promote metastasis

T K Das1, D Dana, S S Paroly

  • 1Department of Developmental and Regenerative Biology, Mount Sinai School of Medicine, New York, NY, USA.

Oncogenesis
|September 11, 2013
PubMed

Insights

Centrosomal kinase Nek2 overexpression drives cancer metastasis by activating growth pathways and altering cell migration. Novel compounds targeting Nek2 show potential to reverse these aggressive tumor phenotypes.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Centrosomal kinase Nek2 is frequently overexpressed in various cancers.
  • Its precise role in tumorigenesis and metastasis is not fully understood.

Purpose of the Study:

  • To investigate the role of Nek2 in cancer progression and metastasis using a Drosophila model and human cell lines.
  • To identify potential therapeutic strategies targeting Nek2.

Main Methods:

  • Overexpression of dNek2 in Drosophila melanogaster models.
  • Analysis of cell migration markers (Rho1, Rac1, E-cadherin) and signaling pathways (Wnt, RTK, MAPK, PI3K, Akt, Ras, Src).
  • In vitro studies using human lung adenocarcinoma (A549) and HEK293T cells.
  • Computational drug discovery to identify Nek2 inhibitors.

Main Results:

  • dNek2 overexpression upregulated Wingless (Wg) and altered cell migration markers, affecting cell shape and morphogenesis.
  • dNek2 cooperated with growth signaling pathways to promote invasion and metastasis.
  • Inhibition of the PI3K pathway suppressed Nek2's cooperative effects.
  • Human Nek2 overexpression activated Akt and increased β-catenin levels in cancer cells.
  • Identified Nek2-inhibitory compounds and a pharmacophore that reversed phenotypes.

Conclusions:

  • Nek2 plays a significant role in promoting cancer metastasis beyond its known role in chromosomal instability.
  • Nek2's involvement in activating key growth and migration pathways provides a rationale for targeting it in cancer therapy.
  • Identified compounds offer a promising therapeutic avenue for treating Nek2-driven cancers.

More Related Videos

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane05:36

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane

Published on: February 8, 2020

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Centrosome Duplication02:25

Centrosome Duplication

The primary microtubule organizing center (MTOC) in animal cells is the centrosome. A centrosome has two cylindrical centrioles at its core. Each centriole consists of nine sets of three microtubules held together by proteins. The centrioles are positioned at right angles to each other and surrounded by a shapeless protein cloud called the pericentriolar matrix, or pericentriolar material (PCM).
To ensure that each daughter cell receives a centrosome after cell division, centrosome duplication...
Centrosome Duplication02:25

Centrosome Duplication

The primary microtubule organizing center (MTOC) in animal cells is the centrosome. A centrosome has two cylindrical centrioles at its core. Each centriole consists of nine sets of three microtubules held together by proteins. The centrioles are positioned at right angles to each other and surrounded by a shapeless protein cloud called the pericentriolar matrix, or pericentriolar material (PCM).
To ensure that each daughter cell receives a centrosome after cell division, centrosome duplication...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...